Evidence map›Paper›PMID 36862316›Full record

ArticleBrain informatics2023

Machine learning determination of applied behavioral analysis treatment plan type.

Jenish Maharjan, Anurag Garikipati, Frank A Dinenno, Madalina Ciobanu, Gina Barnes, Ella Browning, Jenna DeCurzio, Qingqing Mao, Ritankar Das

Registry-linked trialAbstract read
In one paragraph

Article in Brain informatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06204536 (The Efficacy of Technology-Based Tools in Applied Behavior Analysis Treatment Planning for Autism Spectrum Disorder), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06204536 phase1 / phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

The Efficacy of Technology-Based Tools in Applied Behavior Analysis Treatment Planning for Autism Spectrum Disorder

TypeinterventionalSponsorMontera Health Texas LLCRan2025 to 2027Enrolled20ConditionsAutism Spectrum DisorderArmsTech-enabled ABA treatment planning
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Machine Learning Differentiation of Autism Spectrum Sub-Classifications.Journal of autism and developmental disorders · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jenish MaharjanMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.
Anurag GarikipatiMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.
Frank A DinennoMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.
Madalina CiobanuMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.
Gina BarnesMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.
Ella BrowningMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.
Jenna DeCurzioMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.
Qingqing MaoMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA. qmao@fortahealth.com.
Ritankar DasMontera Inc. dba Forta, 548 Market St, San Francisco, CA, PMB 89605, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApplied behavioral analysis (ABA) is regarded as the gold standard treatment for autism spectrum disorder (ASD) and has the potential to improve outcomes for patients with ASD. It can be delivered at different intensities, which are classified as comprehensive or focused treatment approaches. Comprehensive ABA targets multiple developmental domains and involves 20-40 h/week of treatment. Focused ABA targets individual behaviors and typically involves 10-20 h/week of treatment. Determining the appropriate treatment intensity involves patient assessment by trained therapists, however, the final determination is highly subjective and lacks a standardized approach. In our study, we examined the ability of a machine learning (ML) prediction model to classify which treatment intensity would be most suited individually for patients with ASD who are undergoing ABA treatment.

methodsRetrospective data from 359 patients diagnosed with ASD were analyzed and included in the training and testing of an ML model for predicting comprehensive or focused treatment for individuals undergoing ABA treatment. Data inputs included demographics, schooling, behavior, skills, and patient goals. A gradient-boosted tree ensemble method, XGBoost, was used to develop the prediction model, which was then compared against a standard of care comparator encompassing features specified by the Behavior Analyst Certification Board treatment guidelines. Prediction model performance was assessed via area under the receiver-operating characteristic curve (AUROC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).

resultsThe prediction model achieved excellent performance for classifying patients in the comprehensive versus focused treatment groups (AUROC: 0.895; 95% CI 0.811-0.962) and outperformed the standard of care comparator (AUROC 0.767; 95% CI 0.629-0.891). The prediction model also achieved sensitivity of 0.789, specificity of 0.808, PPV of 0.6, and NPV of 0.913. Out of 71 patients whose data were employed to test the prediction model, only 14 misclassifications occurred. A majority of misclassifications (n = 10) indicated comprehensive ABA treatment for patients that had focused ABA treatment as the ground truth, therefore still providing a therapeutic benefit. The three most important features contributing to the model's predictions were bathing ability, age, and hours per week of past ABA treatment.

conclusionThis research demonstrates that the ML prediction model performs well to classify appropriate ABA treatment plan intensity using readily available patient data. This may aid with standardizing the process for determining appropriate ABA treatments, which can facilitate initiation of the most appropriate treatment intensity for patients with ASD and improve resource allocation.

Indexed as

Applied behavioral analysisArtificial intelligenceAutism spectrum disorderMachine learning

Identifiers

PMID36862316
PMCPMC9981822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.